View Information Collection (IC) List View Supporting Statement and Other Documents
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.


View ICR - OIRA Conclusion



0910-0497 200404-0910-001
Historical Active 200209-0910-003
HHS/FDA
Focus Groups as Used by the Food and Drug Administration
Extension without change of a currently approved collection   No
Regular
Approved with change 08/05/2004
Retrieve Notice of Action (NOA) 04/08/2004
This generic clearance for FDA focus groups is approved for 18 months under the following conditions: 1) FDA shall submit memos for individual focus groups (e.g., statement of need, intended use of information, description of respondents, information collection procedures, expected response rate, justification for incentive, estimated burden, participant screener, and moderator guide) 2) OMB will respond with clearance or questions within 10 working days 3) OMB and FDA will jointly evaluate the generic clearance upon resubmission in 18 months. Upon resubmission, FDA will provide a summary of each collection approved under the generic clearance (e.g., actual response rate, use of information).
  Inventory as of this Action Requested Previously Approved
02/28/2006 02/28/2006 08/31/2004
1,674 0 1,683
2,830 0 3,352
0 0 0